Global Neuromodulation Device Market Size, Share, Trends, and Forecast, 2026-2032: SCS, DBS, and Nerve Stimulation | $8 Billion Outlook as Rechargeable Implants Fuel Growth

Global Neuromodulation Device Market Size, Share, Trends, and Forecast, 2026-2032: SCS, DBS, and Nerve Stimulation | $8 Billion Outlook as Rechargeable Implants Fuel Growth Dublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "Neuromodulation Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Spinal Cord Stimulation, Deep Brain Stimulation, and 3 more" has been added to ResearchAndMarkets.com's offering.

The global neuromodulation device market was valued at $5.9 billion in 2025 and is projected to reach $8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 4.4%. Growth is expected to remain steady as procedure volumes increase, clinical applications expand, and technological advancements improve treatment options across major global markets.

The report analyzes spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation. The SCS market is further segmented into generators and leads. Historical data from 2022 to 2024, a 2025 base year, and forecasts from 2026 through 2032 provide detailed visibility into procedure volumes, unit sales, average selling prices (ASPs), market values, growth rates, and company shares.

Neuromodulation Device Market Growth

Market expansion will be primarily volume-driven, with unit sales increasing across the five therapy categories. Although growth rates are expected to moderate as established markets mature, broader clinical indications, rising physician adoption, and continued product innovation will support long-term demand. ASPs are projected to decline modestly due to pricing competition, rechargeable device adoption, and evolving purchasing dynamics.

SCS remains the largest and most commercially active neuromodulation segment. Product development is focused on extended battery life, smaller and lighter implantable systems, expanded programming capabilities, and advanced stimulation modes. High-frequency stimulation, burst stimulation, and wireless injectable devices are broadening treatment options and may increase adoption among patients and care settings where conventional implantation presents clinical or logistical barriers.

Key Market Drivers

Market Limiters

Rechargeable devices introduce compliance requirements that may restrict adoption among some patient populations. Patients must maintain regular charging schedules to preserve therapy performance. This requirement can be challenging for elderly individuals and patients with limited manual dexterity, preventing rechargeable systems from fully replacing primary cell alternatives.

Patent constraints also influence competition within the high-frequency SCS market. Nevro's patented HF10 therapy operates at 10 kHz and has FDA labeling indicating superiority compared with traditional SCS therapy. Following patent litigation involving Stimwave, competing systems are subject to frequency limitations below 3 kHz, according to the report. This supports Nevro's differentiated position in paresthesia-free high-frequency stimulation while limiting direct competition in the 10 kHz category.

Competitive Landscape

The global neuromodulation device market is moderately concentrated, with Medtronic, Abbott, and Boston Scientific holding the leading positions in 2025. Specialty manufacturers, including Nevro, also maintain strategically important positions through differentiated technologies.

Market Coverage

The report evaluates the global neuromodulation device market across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Care settings include hospitals, ambulatory surgery centers, pain management clinics, and neurology specialty clinics.

Quantitative coverage includes market size, procedure numbers, unit sales, ASPs, market shares, growth rates, and forecasts. Qualitative analysis addresses competitive positioning, SWOT analysis for leading companies, mergers and acquisitions, product portfolios, technology trends, and market constraints. Findings draw on interviews with industry leaders and implanting physicians, regulatory information, hospital procurement records, import and export data, and proprietary research databases.

Strategic Value of the Report

The analysis helps neuromodulation device manufacturers, investors, healthcare providers, and other stakeholders identify the largest and fastest-growing opportunities through 2032. It examines how rechargeable generators, longer battery life, device miniaturization, and emerging stimulation modalities are changing product mix, replacement cycles, pricing, and competitive strategy.

The report also supports company benchmarking, product development planning, market entry assessment, and commercial strategy across SCS, DBS, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation. Particular attention is given to ASP trends, clinical indication expansion, patent-related constraints, patient compliance risks, and adoption opportunities in emerging markets.

The deliverable includes 155 pages of analysis, tables, and figures, along with 6 charts and 113 figures covering market segmentation and performance metrics. Licensing options include single-user, site, and enterprise access.

Key Topics Covered:

Research Methodology

Step 1: Project Initiation & Team Selection

Step 2: Prepare Data Systems And Perform Secondary Research

Step 3: Preparation For Interviews & Questionnaire Design

Step 4: Performing Primary Research

Step 5: Research Analysis: Establishing Baseline Estimates

Step 6: Market Forecast And Analysis

Step 7: Identify Strategic Opportunities

Step 8: Final Review And Market Release

Step 9: Customer Feedback And Market Monitoring

Impact of Global Tariffs

Neuromodulation Device Market

13.1 Executive Summary

13.1.1 Global Neuromodulation Device Market Overview

13.1.2 Competitive Analysis

13.1.3 Procedures Included

13.1.4 Markets Included

13.1.5 Regions Included

13.2 Introduction

13.2.1 Spinal Cord Stimulation

13.2.2 Deep Brain Stimulation

13.2.3 Sacral Nerve Stimulation

13.2.4 Vagus Nerve Stimulation

13.2.5 Gastric Electric Stimulation

13.3 Procedure Numbers

13.3.1 Total Neuromodulation Procedures

13.3.2 Spinal Cord Stimulation Procedures

13.3.3 Deep Brain Stimulation Procedures

13.3.4 Sacral Nerve Stimulation Procedures

13.3.5 Vagus Nerve Stimulation Procedures

13.3.6 Gastric Electric Stimulation Procedures

13.4 Market Overview

13.4.1 By Segment

13.4.2 By Region

13.5 Market Analysis And Forecast

13.5.1 Total Neuromodulation Device Market

13.5.2 Spinal Cord Stimulation Market

13.5.2.1 Generator Market

13.5.2.2 Lead Market

13.5.3 Deep Brain Stimulation Market

13.5.4 Sacral Nerve Stimulation Market

13.5.5 Vagus Nerve Stimulation Market

13.5.6 Gastric Electric Stimulation Market

13.6 Drivers And Limiters

13.6.1 Market Drivers

13.6.2 Market Limiters

13.7 Competitive Market Share Analysis

Appendix

List of Charts

Chart 13-1: Neuromodulation Device Market, Global, 2025 & 2032

Chart 13-2: Neuromodulation Device Procedures, Global, 2025

Chart 13-3: Total Neuromodulation Procedures by Region, Global, 2022 - 2032

Chart 13-4: Neuromodulation Device Market by Segment, Global, 2022 - 2032

Chart 13-5: Neuromodulation Device Market by Region, Global, 2022 - 2032

Chart 13-6: Leading Competitors, Neuromodulation Device Market, Global, 2025

List of Figures [113]

For more information about this report visit https://www.researchandmarkets.com/r/wun1jv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.